BK polyomavirus: Emerging pathogen

Microbes and Infection

Volumn 14, Issue 9, 2012, Pages 672-683

  Bennett, Shauna M ^a   Broekema, Nicole M ^a   Imperiale, Michael J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

BKPyV; Polyomavirus; Transplantation

Indexed keywords

CIDOFOVIR; CIDOFOVIR 3 HEXADECYLOXYPROPYL ESTER; CIPROFLOXACIN; GATAFLOXACIN; IMMUNOGLOBULIN; LEFLUNOMIDE; LEVOFLOXACIN; MANITIMUS; QUINOLONE DERIVATIVE; RAPAMYCIN; REGULATOR PROTEIN; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; BK VIRUS INFECTION; CELL MIGRATION; CYTOMEGALOVIRUS RETINITIS; DRUG MECHANISM; HEMORRHAGIC CYSTITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; KIDNEY DISEASE; KIDNEY GRAFT REJECTION; LIFE CYCLE STAGE; LOW DRUG DOSE; MORBIDITY; NEPHROTOXICITY; NONHUMAN; POLYOMAVIRUS ASSOCIATED NEPHROPATHY; PRIORITY JOURNAL; PROPHYLAXIS; RECEPTOR BINDING; RHEUMATOID ARTHRITIS; SHORT SURVEY; VIREMIA; VIRUS ENTRY; VIRUS REACTIVATION; VIRUS REPLICATION; VIRUS TRANSMISSION; VIRUS UNCOATING;

BK VIRUS; BONE MARROW TRANSPLANTATION; COMMUNICABLE DISEASES, EMERGING; HUMANS; IMMUNOCOMPROMISED HOST; KIDNEY TRANSPLANTATION; POLYOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS;

BK POLYOMAVIRUS; DNA VIRUSES; POLYOMAVIRUS;

EID: 84863101618     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2012.02.002     Document Type: Short Survey

References (116)

1. Gardner S.D., Field A.M., Coleman D.V., Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1971, 1:1253-1257.
2. Padgett B.L., Walker D.L., ZuRhein G.M., Eckroade R.J., Dessel B.H. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet 1971, 1:1257-1260.
3. Johne R., Buck C.B., Allander T., Atwood W.J., Garcea R.L., Imperiale M.J., Major E.O., Ramqvist T., Norkin L.C. Taxonomical developments in the family polyomaviridae. Arch. Virol. 2011, 156:1627-1634.
4. Feng H., Shuda M., Chang Y., Moore P.S. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 2008, 319:1096-1100.
5. van der Meijden E., Janssens R.W., Lauber C., Bouwes Bavinck J.N., Gorbalenya A.E., Feltkamp M.C. Discovery of a new human polyomavirus associated with trichodysplasia spinulosa in an immunocompromized patient. PLoS Pathog. 2010, 6:e1001024.
6. Gaynor A.M., Nissen M.D., Whiley D.M., Mackay I.M., Lambert S.B., Wu G., Brennan D.C., Storch G.A., Sloots T.P., Wang D. Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog. 2007, 3:e64.
7. Schowalter R.M., Pastrana D.V., Pumphrey K.A., Moyer A.L., Buck C.B. Merkel cell polyomavirus and two previously unknown polyomaviruses are chronically shed from human skin. Cell Host Microbe 2010, 7:509-515.
8. Scuda N., Hofmann J., Calvignac-Spencer S., Ruprecht K., Liman P., Kuhn J., Hengel H., Ehlers B. A novel human polyomavirus closely related to the African green monkey-derived lymphotropic polyomavirus. J. Virol. 2011, 85:4586-4590.
9. Allander T., Andreasson K., Gupta S., Bjerkner A., Bogdanovic G., Persson M.A., Dalianis T., Ramqvist T., Andersson B. Identification of a third human polyomavirus. J. Virol. 2007, 81:4130-4136.
10. Imperiale M.J., Major E.O. Polyomaviruses. Fields Virology 2007, 2263-2298. Lippincott Williams & Wilkins, Philadelphia. D.M. Knipe, P.M. Howley (Eds.).
11. Doerries K. Human polyomavirus JC and BK persistent infection. Adv. Exp. Med. Biol. 2006, 577:102-116.
12. Jiang M., Abend J.R., Johnson S.F., Imperiale M.J. The role of polyomaviruses in human disease. Virology 2009, 384:266-273.
13. Jin L., Gibson P.E., Booth J.C., Clewley J.P. Genomic typing of BK virus in clinical specimens by direct sequencing of polymerase chain reaction products. J. Med. Virol. 1993, 41:11-17.
14. Goudsmit J., Wertheim-van Dillen P., van Strien A., van der Noordaa J. The role of BK virus in acute respiratory tract disease and the presence of BKV DNA in tonsils. J. Med. Virol. 1982, 10:91-99.
15. Knowles W.A. Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV). Adv. Exp. Med. Biol. 2006, 577:19-45.
16. Heritage J., Chesters P.M., McCance D.J. The persistence of papovavirus BK DNA sequences in normal human renal tissue. J. Med. Virol. 1981, 8:143-150.
17. Shinohara T., Matsuda M., Cheng S.H., Marshall J., Fujita M., Nagashima K. BK virus infection of the human urinary tract. J. Med. Virol. 1993, 41:301-305.
18. Chatterjee M., Weyandt T.B., Frisque R.J. Identification of archetype and rearranged forms of BK virus in leukocytes from healthy individuals. J. Med. Virol. 2000, 60:353-362.
19. Knowles W.A., Gibson P.E., Gardner S.D. Serological typing scheme for BK-like isolates of human polyomavirus. J. Med. Virol. 1989, 28:118-123.
20. Zhong S., Randhawa P.S., Ikegaya H., Chen Q., Zheng H.Y., Suzuki M., Takeuchi T., Shibuya A., Kitamura T., Yogo Y. Distribution patterns of BK polyomavirus (BKV) subtypes and subgroups in American, European and Asian populations suggest co-migration of BKV and the human race. J. Gen. Virol. 2009, 90:144-152.
21. Sharma P.M., Gupta G., Vats A., Shapiro R., Randhawa P. Phylogenetic analysis of polyomavirus BK sequences. J. Virol. 2006, 80:8869-8879.
22. Dropulic L.K., Jones R.J. Polyomavirus BK infection in blood and marrow transplant recipients. Bone Marrow Transplant. 2008, 41:11-18.
23. Droller M.J., Saral R., Santos G. Prevention of cyclophosphamide-induced hemorrhagic cystitis. Urology 1982, 20:256-258.
24. Cox P.J. Cyclophosphamide cystitis-identification of acrolein as the causative agent. Biochem. Pharmacol. 1979, 28:2045-2049.
25. Erard V., Kim H.W., Corey L., Limaye A., Huang M.L., Myerson D., Davis C., Boeckh M. BK DNA viral load in plasma: evidence for an association with hemorrhagic cystitis in allogeneic hematopoietic cell transplant recipients. Blood 2005, 106:1130-1132.
26. Wong A.S., Chan K.H., Cheng V.C., Yuen K.Y., Kwong Y.L., Leung A.Y. Relationship of pretransplantation polyoma BK virus serologic findings and BK viral reactivation after hematopoietic stem cell transplantation. Clin. Infect. Dis. 2007, 44:830-837.
27. Boothpur R., Brennan D.C. Human polyoma viruses and disease with emphasis on clinical BK and JC. J. Clin. Virol. 2010, 47:306-312.
28. Ramos E., Drachenberg C.B., Wali R., Hirsch H.H. The decade of polyomavirus BK-associated nephropathy: state of affairs. Transplantation 2009, 87:621-630.
29. B. Suwelack, V. Malyar, M. Koch, M. Sester, C. Sommerer, The influence of immunosuppressive agents on BK virus risk following kidney transplantation, and implications for choice of regimen, Transplant. Rev. (Orlando) in press.
30. Binet I., Nickeleit V., Hirsch H.H., Prince O., Dalquen P., Gudat F., Mihatsch M.J., Thiel G. Polyomavirus disease under new immunosuppressive drugs: a cause of renal graft dysfunction and graft loss. Transplantation 1999, 67:918-922.
31. Randhawa P.S., Khaleel-Ur-Rehman K., Swalsky P.A., Vats A., Scantlebury V., Shapiro R., Finkelstein S. DNA sequencing of viral capsid protein VP-1 region in patients with BK virus interstitial nephritis. Transplantation 2002, 73:1090-1094.
32. Nickeleit V., Hirsch H.H., Binet I.F., Gudat F., Prince O., Dalquen P., Thiel G., Mihatsch M.J. Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease. J. Am. Soc. Nephrol. 1999, 10:1080-1089.
33. Hirsch H.H., Knowles W., Dickenmann M., Passweg J., Klimkait T., Mihatsch M.J., Steiger J. Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients. N. Engl. J. Med. 2002, 347:488-496.
34. Hirsch H.H., Brennan D.C., Drachenberg C.B., Ginevri F., Gordon J., Limaye A.P., Mihatsch M.J., Nickeleit V., Ramos E., Randhawa P., Shapiro R., Steiger J., Suthanthiran M., Trofe J. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 2005, 79:1277-1286.
35. Galan A., Rauch C.A., Otis C.N. Fatal BK polyoma viral pneumonia associated with immunosuppression. Hum. Pathol. 2005, 36:1031-1034.
36. Sandler E.S., Aquino V.M., Goss-Shohet E., Hinrichs S., Krisher K. BK papova virus pneumonia following hematopoietic stem cell transplantation. Bone Marrow Transplant. 1997, 20:163-165.
37. Cubukcu-Dimopulo O., Greco A., Kumar A., Karluk D., Mittal K., Jagirdar J. BK virus infection in AIDS. Am. J. Surg. Pathol. 2000, 24:145-149.
38. Nickeleit V., Mihatsch M.J. Polyomavirus nephropathy in native kidneys and renal allografts: an update on an escalating threat. Transpl. Int. 2006, 19:960-973.
39. Ali F.N., Meehan S.M., Pahl E., Cohn R.A. Native BK viral nephropathy in a pediatric heart transplant recipient. Pediatr. Transplant. 2010, 14:E38-E41.
40. Sahney S., Yorgin P., Zuppan C., Cutler D., Kambham N., Chinnock R. BK virus nephropathy in the native kidneys of a pediatric heart transplant recipient. Pediatr. Transplant. 2010, 14:E11-E15.
41. Verghese P.S., Finn L.S., Englund J.A., Sanders J.E., Hingorani S.R. BK nephropathy in pediatric hematopoietic stem cell transplant recipients. Pediatr. Transplant. 2009, 13:913-918.
42. Li T.C., Takeda N., Kato K., Nilsson J., Xing L., Haag L., Cheng R.H., Miyamura T. Characterization of self-assembled virus-like particles of human polyomavirus BK generated by recombinant baculoviruses. Virology 2003, 311:115-124.
43. Schelhaas M., Malmstrom J., Pelkmans L., Haugstetter J., Ellgaard L., Grunewald K., Helenius A. Simian virus 40 depends on ER protein folding and quality control factors for entry into host cells. Cell 2007, 131:516-529.
44. Krauzewicz N., Streuli C.H., Stuart-Smith N., Jones M.D., Wallace S., Griffin B.E. Myristylated polyomavirus VP2: role in the life cycle of the virus. J. Virol. 1990, 64:4414-4420.
45. Gharakhanian E., Munoz L., Mayorca L. The simian virus 40 minor structural protein Vp3, but not Vp2, is essential for infectious virion formation. J. Gen. Virol. 2003, 84:2111-2116.
46. Nakanishi A., Itoh N., Li P.P., Handa H., Liddington R.C., Kasamatsu H. Minor capsid proteins of simian virus 40 are dispensable for nucleocapsid assembly and cell entry but are required for nuclear entry of the viral genome. J. Virol. 2007, 81:3778-3785.
47. Sinibaldi L., Viti D., Goldoni P., Cavallo G., Caroni C., Orsi N. Inhibition of BK virus haemagglutination by gangliosides. J. Gen. Virol. 1987, 68:879-883.
48. Low J., Humes H.D., Szczypka M., Imperiale M. BKV and SV40 infection of human kidney tubular epithelial cells in vitro. Virology 2004, 323:182-188.
49. Low J.A., Magnuson B., Tsai B., Imperiale M.J. Identification of gangliosides GD1b and GT1b as receptors for BK virus. J. Virol. 2006, 80:1361-1366.
50. Drachenberg C.B., Papadimitriou J.C., Wali R., Cubitt C.L., Ramos E. BK polyoma virus allograft nephropathy: ultrastructural features from viral cell entry to lysis. Am. J. Transplant. 2003, 3:1383-1392.
51. Maraldi N.M., Barbanti-Brodano G., Portolani M., La Placa M. Ultrastructural aspects of BK virus uptake and replication in human fibroblasts. J. Gen. Virol. 1975, 27:71-80.
52. Dugan A.S., Eash S., Atwood W.J. Update on BK virus entry and intracellular trafficking. Transpl. Infect. Dis. 2006, 8:62-67.
53. Pho M.T., Ashok A., Atwood W.J. JC virus enters human glial cells by clathrin-dependent receptor-mediated endocytosis. J. Virol. 2000, 74:2288-2292.
54. Bastiani M., Parton R.G. Caveolae at a glance. J. Cell Sci. 2010, 123:3831-3836.
55. Moriyama T., Marquez J.P., Wakatsuki T., Sorokin A. Caveolar endocytosis is critical for BK virus infection of human renal proximal tubular epithelial cells. J. Virol. 2007, 81:8552-8562.
56. Eash S., Querbes W., Atwood W.J. Infection of vero cells by BK virus is dependent on caveolae. J. Virol. 2004, 78:11583-11590.
57. Benmerah A., Bayrou M., Cerf-Bensussan N., Dautry-Varsat A. Inhibition of clathrin-coated pit assembly by an Eps15 mutant. J. Cell Sci. 1999, 112(Pt 9):1303-1311.
58. Jiang M., Abend J.R., Tsai B., Imperiale M.J. Early events during BK virus entry and disassembly. J. Virol. 2009, 83:1350-1358.
59. Engel S., Heger T., Mancini R., Herzog F., Kartenbeck J., Hayer A., Helenius A. Role of endosomes in simian virus 40 entry and infection. J. Virol. 2011, 85:4198-4211.
60. Querbes W., O'Hara B.A., Williams G., Atwood W.J. Invasion of host cells by JC virus identifies a novel role for caveolae in endosomal sorting of noncaveolar ligands. J. Virol. 2006, 80:9402-9413.
61. Tsai B., Qian M. Cellular entry of polyomaviruses. Curr. Top. Microbiol. Immunol. 2010, 343:177-194.
62. Eash S., Atwood W.J. Involvement of cytoskeletal components in BK virus infectious entry. J. Virol. 2005, 79:11734-11741.
63. Moriyama T., Sorokin A. Intracellular trafficking pathway of BK virus in human renal proximal tubular epithelial cells. Virology 2008, 371:336-349.
64. Walczak C.P., Tsai B. A PDI family network acts distinctly and coordinately with ERp29 to facilitate polyomavirus infection. J. Virol. 2011, 85:2386-2396.
65. Magnuson B., Rainey E.K., Benjamin T., Baryshev M., Mkrtchian S., Tsai B. ERp29 triggers a conformational change in polyomavirus to stimulate membrane binding. Mol. Cell. 2005, 20:289-300.
66. Lilley B.N., Gilbert J.M., Ploegh H.L., Benjamin T.L. Murine polyomavirus requires the endoplasmic reticulum protein derlin-2 to initiate infection. J. Virol. 2006, 80:8739-8744.
67. Smith M.H., Ploegh H.L., Weissman J.S. Road to ruin: targeting proteins for degradation in the endoplasmic reticulum. Science 2011, 334:1086-1090.
68. Inoue T., Tsai B. A large and intact viral particle penetrates the endoplasmic reticulum membrane to reach the cytosol. PLoS Pathog. 2011, 7:e1002037.
69. Goodwin E.C., Lipovsky A., Inoue T., Magaldi T.G., Edwards A.P., Van Goor K.E., Paton A.W., Paton J.C., Atwood W.J., Tsai B., DiMaio D. BiP and multiple DNAJ molecular chaperones in the endoplasmic reticulum are required for efficient simian virus 40 infection. MBio. 2011, 2:e00101-e00111.
70. Geiger R., Andritschke D., Friebe S., Herzog F., Luisoni S., Heger T., Helenius A. BAP31 and BiP are essential for dislocation of SV40 from the endoplasmic reticulum to the cytosol. Nat. Cell Biol. 2011, 13:1305-1314.
71. Fahrenkrog B., Aebi U. The nuclear pore complex: nucleocytoplasmic transport and beyond. Nat. Rev. Mol. Cell Biol. 2003, 4:757-766.
72. Pante N., Kann M. Nuclear pore complex is able to transport macromolecules with diameters of about 39 nm. Mol. Biol. Cell 2002, 13:425-434.
73. Nakanishi A., Li P.P., Qu Q., Jafri Q.H., Kasamatsu H. Molecular dissection of nuclear entry-competent SV40 during infection. Virus Res. 2007, 124:226-230.
74. Nakanishi A., Shum D., Morioka H., Otsuka E., Kasamatsu H. Interaction of the Vp3 nuclear localization signal with the importin alpha 2/beta heterodimer directs nuclear entry of infecting simian virus 40. J. Virol. 2002, 76:9368-9377.
75. Cubitt C.L. Molecular genetics of the BK virus. Polyomaviruses and Human Disease 2006, 85-95. Springer Science, Georgetown, TX. N. Ahsan (Ed.).
76. Harris K.F., Christensen J.B., Imperiale M.J. BK virus large T antigen: interactions with the retinoblastoma family of tumor suppressor proteins and effects on cellular growth control. J. Virol. 1996, 70:2378-2386.
77. Felsani A., Mileo A.M., Paggi M.G. Retinoblastoma family proteins as key targets of the small DNA virus oncoproteins. Oncogene 2006, 25:5277-5285.
78. Harris K.F., Christensen J.B., Radany E.H., Imperiale M.J. Novel mechanisms of E2F induction by BK virus large T antigen: requirement of both the pRb binding and J domains. Mol. Cell. Biol. 1998, 18:1746-1756.
79. Yang S.I., Lickteig R.L., Estes R., Rundell K., Walter G., Mumby M.C. Control of protein phosphatase 2A by simian virus 40 small-t antigen. Mol. Cell. Biol. 1991, 11:1988-1995.
80. Skoczylas C., Fahrbach K.M., Rundell K. Cellular targets of the SV40 small-t antigen in human cell transformation. Cell Cycle 2004, 3:606-610.
81. Pipas J.M. Common and unique features of T antigens encoded by the polyomavirus group. J. Virol. 1992, 66:3979-3985.
82. Abend J.R., Joseph A.E., Das D., Campbell-Cecen D.B., Imperiale M.J. A truncated T antigen expressed from an alternatively spliced BK virus early mRNA. J. Gen. Virol. 2009, 90:1238-1245.
83. Tognon M., Corallini A., Martini F., Negrini M., Barbanti-Brodano G. Oncogenic transformation by BK virus and association with human tumors. Oncogene 2003, 22:5192-5200.
84. Fanning E., Zhao K. SV40 DNA replication: from the A gene to a nanomachine. Virology 2009, 384:352-359.
85. Broekema N.M., Imperiale M.J. Efficient propagation of archetype BK and JC polyomaviruses. Virology 2012, 422:235-241.
86. Broekema N.M., Abend J.R., Bennett S.M., Butel J.S., Vanchiere J.A., Imperiale M.J. A system for the analysis of BKV non-coding control regions: application to clinical isolates from an HIV/AIDS patient. Virology 2010, 407:368-373.
87. Olsen G.H., Hirsch H.H., Rinaldo C.H. Functional analysis of polyomavirus BK non-coding control region quasispecies from kidney transplant recipients. J. Med. Virol. 2009, 81:1959-1967.
88. Nakanishi A., Chapellier B., Maekawa N., Hiramoto M., Kuge T., Takahashi R.U., Handa H., Imai T. SV40 vectors carrying minimal sequence of viral origin with exchangeable capsids. Virology 2008, 379:110-117.
89. Jiang M., Entezami P., Gamez M., Stamminger T., Imperiale M.J. Functional reorganization of0 promyelocytic leukemia nuclear bodies during BK virus infection. MBio. 2011, 2:e00281-00310.
90. Babel N., Volk H.D., Reinke P. BK polyomavirus infection and nephropathy: the virus-immune system interplay. Nat. Rev. Nephrol. 2011, 7:399-406.
91. Dugan A.S., Maginnis M.S., Jordan J.A., Gasparovic M.L., Manley K., Page R., Williams G., Porter E., O'Hara B.A., Atwood W.J. Human alpha-defensins inhibit BK virus infection by aggregating virions and blocking binding to host cells. J. Biol. Chem. 2008, 283:31125-31132.
92. Abend J.R., Low J.A., Imperiale M.J. Inhibitory effect of gamma interferon on BK virus gene expression and replication. J. Virol. 2007, 81:272-279.
93. Abend J.R., Low J.A., Imperiale M.J. Global effects of BKV infection on gene expression in human primary kidney epithelial cells. Virology 2010, 397:73-79.
94. Seo G.J., Fink L.H., O'Hara B., Atwood W.J., Sullivan C.S. Evolutionarily conserved function of a viral microRNA. J. Virol. 2008, 82:9823-9828.
95. Bauman Y., Nachmani D., Vitenshtein A., Tsukerman P., Drayman N., Stern-Ginossar N., Lankry D., Gruda R., Mandelboim O. An identical miRNA of the human JC and BK polyoma viruses targets the stress-induced ligand ULBP3 to escape immune elimination. Cell Host Microbe 2011, 9:93-102.
96. Chen Y., Trofe J., Gordon J., Du Pasquier R.A., Roy-Chaudhury P., Kuroda M.J., Woodle E.S., Khalili K., Koralnik I.J. Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy. J. Virol. 2006, 80:3495-3505.
97. Dropulic L.K., Cohen J.I. Update on new antivirals under development for the treatment of double-stranded DNA virus infections. Clin. Pharmacol. Ther. 2010, 88:610-619.
98. FDA approves cidofovir for treatment of CMV retinitis. Food and Drug Administration. J. Int. Assoc. Physicians AIDS Care 1996, 2:30.
99. Savona M.R., Newton D., Frame D., Levine J.E., Mineishi S., Kaul D.R. Low-dose cidofovir treatment of BK virus-associated hemorrhagic cystitis in recipients of hematopoietic stem cell transplant. Bone Marrow Transplant. 2007, 39:783-787.
100. Safrin S., Cherrington J., Jaffe H.S. Clinical uses of cidofovir. Rev. Med. Virol. 1997, 7:145-156.
101. Rinaldo C.H., Gosert R., Bernhoff E., Finstad S., Hirsch H.H. 1-O-hexadecyloxypropyl cidofovir (CMX001) effectively inhibits polyomavirus BK replication in primary human renal tubular epithelial cells. Antimicrob. Agents Chemother. 2010, 54:4714-4722.
102. Farasati N.A., Shapiro R., Vats A., Randhawa P. Effect of leflunomide and cidofovir on replication of BK virus in an in vitro culture system. Transplantation 2005, 79:116-118.
103. Bernhoff E., Tylden G.D., Kjerpeseth L.J., Gutteberg T.J., Hirsch H.H., Rinaldo C.H. Leflunomide inhibition of BK virus replication in renal tubular epithelial cells. J. Virol. 2010, 84:2150-2156.
104. Josephson M.A., Gillen D., Javaid B., Kadambi P., Meehan S., Foster P., Harland R., Thistlethwaite R.J., Garfinkel M., Atwood W., Jordan J., Sadhu M., Millis M.J., Williams J. Treatment of renal allograft polyoma BK virus infection with leflunomide. Transplantation 2006, 81:704-710.
105. Guasch A., Roy-Chaudhury P., Woodle E.S., Fitzsimmons W., Holman J., First M.R. Assessment of efficacy and safety of FK778 in comparison with standard care in renal transplant recipients with untreated BK nephropathy. Transplantation 2010, 90:891-897.
106. Portolani M., Pietrosemoli P., Cermelli C., Mannini-Palenzona A., Grossi M.P., Paolini L., Barbanti-Brodano G. Suppression of BK virus replication and cytopathic effect by inhibitors of prokaryotic DNA gyrase. Antivir. Res. 1988, 9:205-218.
107. Ali S.H., Chandraker A., DeCaprio J.A. Inhibition of simian virus 40 large T antigen helicase activity by fluoroquinolones. Antivir. Ther. 2007, 12:1-6.
108. Gabardi S., Waikar S.S., Martin S., Roberts K., Chen J., Borgi L., Sheashaa H., Dyer C., Malek S.K., Tullius S.G., Vadivel N., Grafals M., Abdi R., Najafian N., Milford E., Chandraker A. Evaluation of fluoroquinolones for the prevention of BK viremia after renal transplantation. Clin. J. Am. Soc. Nephrol. 2010, 5:1298-1304.
109. Leung A.Y., Chan M.T., Yuen K.Y., Cheng V.C., Chan K.H., Wong C.L., Liang R., Lie A.K., Kwong Y.L. Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation. Clin. Infect. Dis. 2005, 40:528-537.
110. Sanchez Fructuoso A.I., Calvo N., Perez-Flores I., Valero R., Rodriguez-Sanchez B., Garcia de Viedma D., Munoz P., Barrientos A. Mammalian target of rapamycin signal inhibitors could play a role in the treatment of BK polyomavirus nephritis in renal allograft recipients. Transpl. Infect. Dis. 2011, 13:584-591.
111. Araki K., Turner A.P., Shaffer V.O., Gangappa S., Keller S.A., Bachmann M.F., Larsen C.P., Ahmed R. mTOR regulates memory CD8 T-cell differentiation. Nature 2009, 460:108-112.
112. Hirsch H.H., Mohaupt M., Klimkait T. Prospective monitoring of BK virus load after discontinuing sirolimus treatment in a renal transplant patient with BK virus nephropathy. J. Infect. Dis. 2001, 184:1494-1495. author reply 1495-1496.
113. Hymes L.C., Warshaw B.L. Five-year experience using sirolimus-based, calcineurin inhibitor-free immunosuppression in pediatric renal transplantation. Pediatr. Transplant. 2011, 15:437-441.
114. Maggiore U., Medici M.C., Vaglio A., Buzio C. Increased viral load after intravenous immunoglobulin therapy for BK virus-associated nephropathy. Transpl. Infect. Dis. 2010, 12:470-472.
115. Bohl D.L., Brennan D.C., Ryschkewitsch C., Gaudreault-Keener M., Major E.O., Storch G.A. BK virus antibody titers and intensity of infections after renal transplantation. J. Clin. Virol. 2008, 43:184-189.
116. Bohl D.L., Storch G.A., Ryschkewitsch C., Gaudreault-Keener M., Schnitzler M.A., Major E.O., Brennan D.C. Donor origin of BK virus in renal transplantation and role of HLA C7 in susceptibility to sustained BK viremia. Am. J. Transplant. 2005, 5:2213-2221.